Co-Authors
This is a "connection" page, showing publications co-authored by Ansgar Lohse and Marie Bossert.
Connection Strength
0.506
-
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1273.
Score: 0.229
-
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes Infect. 2020 10; 22(9):500-503.
Score: 0.222
-
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration. Clin Exp Rheumatol. 2020 Jul-Aug; 38(4):742-747.
Score: 0.056